These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
305 related articles for article (PubMed ID: 11027660)
1. Arsenic trioxide inhibits neuroblastoma growth in vivo and promotes apoptotic cell death in vitro. Ora I; Bondesson L; Jönsson C; Ljungberg J; Pörn-Ares I; Garwicz S; Pâhlman S Biochem Biophys Res Commun; 2000 Oct; 277(1):179-85. PubMed ID: 11027660 [TBL] [Abstract][Full Text] [Related]
2. Arsenic trioxide (As2O3)-induced apoptosis and differentiation in retinoic acid-resistant acute promyelocytic leukemia model in hGM-CSF-producing transgenic SCID mice. Kinjo K; Kizaki M; Muto A; Fukuchi Y; Umezawa A; Yamato K; Nishihara T; Hata J; Ito M; Ueyama Y; Ikeda Y Leukemia; 2000 Mar; 14(3):431-8. PubMed ID: 10720138 [TBL] [Abstract][Full Text] [Related]
3. Low dose of arsenic trioxide inhibits multidrug resistant-related P-glycoprotein expression in human neuroblastoma cell line. Liu L; Li Y; Xiong X; Qi K; Zhang C; Fang J; Guo H Int J Oncol; 2016 Dec; 49(6):2319-2330. PubMed ID: 27840903 [TBL] [Abstract][Full Text] [Related]
4. Morphological and biochemical changes induced by arsenic trioxide in neuroblastoma cell lines. Ryu KH; Woo SY; Lee MY; Jung YJ; Yoo ES; Seoh JY; Kie JH; Shin HY; Ahn HS Pediatr Hematol Oncol; 2005; 22(7):609-21. PubMed ID: 16166054 [TBL] [Abstract][Full Text] [Related]
5. Importance of ERK activation in As2O3-induced differentiation and promyelocytic leukemia nuclear bodies formation in neuroblastoma cells. Petit A; Delaune A; Falluel-Morel A; Goullé JP; Vannier JP; Dubus I; Vasse M Pharmacol Res; 2013 Nov; 77():11-21. PubMed ID: 24004656 [TBL] [Abstract][Full Text] [Related]
6. Arsenic-induced apoptosis in malignant cells in vitro. Akao Y; Yamada H; Nakagawa Y Leuk Lymphoma; 2000 Mar; 37(1-2):53-63. PubMed ID: 10721769 [TBL] [Abstract][Full Text] [Related]
7. Arsenic trioxide-induced death of neuroblastoma cells involves activation of Bax and does not require p53. Karlsson J; Øra I; Pörn-Ares I; Påhlman S Clin Cancer Res; 2004 May; 10(9):3179-88. PubMed ID: 15131059 [TBL] [Abstract][Full Text] [Related]
8. Retinoic acid (RA) and As2O3 treatment in transgenic models of acute promyelocytic leukemia (APL) unravel the distinct nature of the leukemogenic process induced by the PML-RARalpha and PLZF-RARalpha oncoproteins. Rego EM; He LZ; Warrell RP; Wang ZG; Pandolfi PP Proc Natl Acad Sci U S A; 2000 Aug; 97(18):10173-8. PubMed ID: 10954752 [TBL] [Abstract][Full Text] [Related]
9. Arsenic trioxide inhibits cell growth in SH-SY5Y and SK-N-AS neuroblastoma cell lines by a different mechanism. Woo SY; Lee MY; Jung YJ; Yoo ES; Seoh JY; Shin HY; Ahn HS; Ryu KH Pediatr Hematol Oncol; 2006; 23(3):231-43. PubMed ID: 16517539 [TBL] [Abstract][Full Text] [Related]
10. Arsenic trioxide inhibits ATRA-induced prostaglandin E2 and cyclooxygenase-1 in NB4 cells, a model of acute promyelocytic leukemia. Habib A; Hamade E; Mahfouz R; Nasrallah MS; de Thé H; Bazarbachi A Leukemia; 2008 Jun; 22(6):1125-30. PubMed ID: 18354491 [TBL] [Abstract][Full Text] [Related]
11. Arsenic trioxide induces apoptosis in neuroblastoma cell lines through the activation of caspase 3 in vitro. Akao Y; Nakagawa Y; Akiyama K FEBS Lett; 1999 Jul; 455(1-2):59-62. PubMed ID: 10428472 [TBL] [Abstract][Full Text] [Related]
12. Src family kinase inhibitor PP2 enhances differentiation of acute promyelocytic leukemia cell line induced by combination of all-trans-retinoic acid and arsenic trioxide. Jung YS; Cheong HJ; Kim SJ; Kim KH; Lee N; Park HS; Won JH Leuk Res; 2014 Aug; 38(8):977-82. PubMed ID: 24953245 [TBL] [Abstract][Full Text] [Related]
13. Differential effects of N-(4-hydroxyphenyl)retinamide and retinoic acid on neuroblastoma cells: apoptosis versus differentiation. Ponzoni M; Bocca P; Chiesa V; Decensi A; Pistoia V; Raffaghello L; Rozzo C; Montaldo PG Cancer Res; 1995 Feb; 55(4):853-61. PubMed ID: 7850799 [TBL] [Abstract][Full Text] [Related]
14. Granulocyte colony-stimulating factor potentiates differentiation induction by all-trans retinoic acid and arsenic trioxide and enhances arsenic uptake in the acute promyelocytic leukemia cell line HT93A. Iriyama N; Yuan B; Hatta Y; Horikoshi A; Yoshino Y; Toyoda H; Aizawa S; Takeuchi J Oncol Rep; 2012 Nov; 28(5):1875-82. PubMed ID: 22940758 [TBL] [Abstract][Full Text] [Related]
15. Methylated metabolites of arsenic trioxide are more potent than arsenic trioxide as apoptotic but not differentiation inducers in leukemia and lymphoma cells. Chen GQ; Zhou L; Styblo M; Walton F; Jing Y; Weinberg R; Chen Z; Waxman S Cancer Res; 2003 Apr; 63(8):1853-9. PubMed ID: 12702573 [TBL] [Abstract][Full Text] [Related]
16. Systems analysis of transcriptome and proteome in retinoic acid/arsenic trioxide-induced cell differentiation/apoptosis of promyelocytic leukemia. Zheng PZ; Wang KK; Zhang QY; Huang QH; Du YZ; Zhang QH; Xiao DK; Shen SH; Imbeaud S; Eveno E; Zhao CJ; Chen YL; Fan HY; Waxman S; Auffray C; Jin G; Chen SJ; Chen Z; Zhang J Proc Natl Acad Sci U S A; 2005 May; 102(21):7653-8. PubMed ID: 15894607 [TBL] [Abstract][Full Text] [Related]
17. Tumor growth inhibition by arsenic trioxide (As2O3) in the orthotopic metastasis model of androgen-independent prostate cancer. Maeda H; Hori S; Nishitoh H; Ichijo H; Ogawa O; Kakehi Y; Kakizuka A Cancer Res; 2001 Jul; 61(14):5432-40. PubMed ID: 11454688 [TBL] [Abstract][Full Text] [Related]
18. HMGI(Y) and HMGI-C genes are expressed in neuroblastoma cell lines and tumors and affect retinoic acid responsiveness. Giannini G; Di Marcotullio L; Ristori E; Zani M; Crescenzi M; Scarpa S; Piaggio G; Vacca A; Peverali FA; Diana F; Screpanti I; Frati L; Gulino A Cancer Res; 1999 May; 59(10):2484-92. PubMed ID: 10344762 [TBL] [Abstract][Full Text] [Related]
19. Arsenic enhances the activation of Stat1 by interferon gamma leading to synergistic expression of IRF-1. Chelbi-alix MK; Bobé P; Benoit G; Canova A; Pine R Oncogene; 2003 Dec; 22(57):9121-30. PubMed ID: 14668793 [TBL] [Abstract][Full Text] [Related]
20. Arsenic trioxide concentration determines the fate of Ewing's sarcoma family tumors and neuroblastoma cells in vitro. Jung HS; Kim HS; Lee MJ; Shin HY; Ahn HS; Ryu KH; Seoh JY; Kim CJ; Jang JJ FEBS Lett; 2006 Sep; 580(20):4969-75. PubMed ID: 16930595 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]